Dendritic cells (DCs) have emerged in the field of cancer immunotherapy as the most potent professional antigen-presenting ...

Promatix Biosciences, which was founded in 2020, says the scarcity of truly tumour-selective targets is putting the brakes on ...

Can WuXi AppTec’s Integrated Discovery Platform Power Oncology? WuXi AppTec’s integrated platform combines high-authority screening, pharmacology, and early assessment in a single end-to-end system.

Recognizing this individuality has driven scientists to research beyond a one-size-fits-all approach to cancer treatment.

Cell division during the early stage of embryo development is a trade-off between speed and accuracy; the cells need to ...

Cancer cells survive by repairing damage to their DNA—even damage that would normally be fatal. One of their most important ...

Pancreatic cancer can remain quiet for years, developing undetected before causing symptoms that lead to a diagnosis. Even ...

Chimeric antigen receptor-T (CAR-T) cell therapy represents a major breakthrough in cancer immunotherapy, providing remarkable clinical benefits for ...

When we treat cancer patients, their disease can overcome treatment through its innate capacity to adapt. This is at the ...

Researchers from Japan have developed biocompatible molecular quantum nanosensors (MoQNs) that can measure temperature and ...

Milk exosomes enable scalable drug delivery, advancing safer therapies for inflammatory disease and cancer care.

Astellas Pharma chief R&D officer Tadaaki Taniguchi at the Astellas Life Sciences Center in Cambridge, Massachusetts. Credit: ...